Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Unicycive Therapeutics, Inc. (UNCY) had Weighted-Average Shares Outstanding (Diluted) of 18.07M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-6.01M |
|
-- |
|
-- |
|
$7.34M |
|
$-7.34M |
|
$1.33M |
|
$-6.01M |
|
$-6.01M |
|
$-6.01M |
|
$-6.01M |
|
$-6.01M |
|
$-6.01M |
|
$-7.34M |
|
$-7.19M |
|
18.07M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
18.07M |
$-0.33 |
|
$-0.33 |
|
| Balance Sheet Financials | |
$50.29M |
|
$0.07M |
|
$0.32M |
|
$50.61M |
|
$13.13M |
|
-- |
|
-- |
|
$13.13M |
|
$37.48M |
|
$37.48M |
|
$37.48M |
|
20.85M |
|
| Cash Flow Statement Financials | |
$-23.29M |
|
$-0.02M |
|
$39.86M |
|
$26.14M |
|
$42.70M |
|
$16.55M |
|
$1.86M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.83 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-23.31M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.04% |
|
-16.04% |
|
-11.88% |
|
-16.04% |
|
$1.80 |
|
$-1.29 |
|
$-1.29 |
|